Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$101.98K

Rothblatt Martine A Chairperson & CEO

Transaction date Aug 13, 2026
Public filing date Aug 14, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$501.27 Aug 13, 2026
First close after public filing
$508.48 Aug 17, 2026
30-day return after filing
-1.14% Through Sep 14, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
200 shares @ $509.92
SEC ownership
Indirect
Transaction code
S
Form
4
Filing identifier
0001106578-26-000120
Filing cohort

Transactions in this filing

Showing 14 of 14
Trades
14
Issuers
1
Estimated value
$6.08M
Buys / sales
0 / 12
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Sale Aug 13, 2026 $122.97K
United Therapeutics Corp UTHR Sale Aug 13, 2026 $665.24K
United Therapeutics Corp UTHR Sale Aug 13, 2026 $849.84K
United Therapeutics Corp UTHR Current Sale Aug 13, 2026 $101.98K
United Therapeutics Corp UTHR Sale Aug 13, 2026 $221.29K
United Therapeutics Corp UTHR Sale Aug 13, 2026 $80.61K
United Therapeutics Corp UTHR Sale Aug 13, 2026 $485.48K
United Therapeutics Corp UTHR Sale Aug 13, 2026 $325.61K
United Therapeutics Corp UTHR Exercise Aug 13, 2026 $0
United Therapeutics Corp UTHR Exercise Aug 13, 2026 $1.29M
United Therapeutics Corp UTHR Sale Aug 13, 2026 $626.6K
United Therapeutics Corp UTHR Sale Aug 13, 2026 $762.35K
United Therapeutics Corp UTHR Sale Aug 13, 2026 $466.57K
United Therapeutics Corp UTHR Sale Aug 13, 2026 $81.78K